Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas.
Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized.
Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in
Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs.
ProPublica articles on generic drugs:
https://www.propublica.org/article/fda-drug-safety-foreign-manufacturers-takeaways
- https://www.propublica.org/article/propublica-fda-lawsuit-drug-safety
- https://www.propublica.org/article/fda-drug-loophole-sun-pharma
- https://www.propublica.org/article/fda-methodology-american-medicine-research
- https://www.propublica.org/article/glenmark-recalls-two-dozen-drugs
HCMA Blog
